Rhythm Pharmaceuticals
RYTM
RYTM
284 hedge funds and large institutions have $6.42B invested in Rhythm Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 101 increasing their positions, 88 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
1.43% less ownership
Funds ownership: 109.17% → 107.74% (-1.4%)
18% less capital invested
Capital invested by funds: $7.8B → $6.42B (-$1.38B)
Holders
284
Holding in Top 10
10
Calls
$16.4M
Puts
$1.87M
Top Buyers
| 1 | +$123M | |
| 2 | +$64.4M | |
| 3 | +$41.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$40.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$39.3M |
Top Sellers
| 1 | -$311M | |
| 2 | -$98.3M | |
| 3 | -$82.5M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$32.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.3M |
